Health & Veritas

Howie and Harlan are joined by Kate Heilpern, president of Yale New Haven Hospital, to discuss the hospital's 200-year history, the financial pressures facing health systems, and how Yale New Haven is balancing innovation with its mission to serve the local community. Harlan examines the growing burden of U.S. healthcare costs; Howie highlights encouraging trends in infant mortality, life expectan...

In this special episode, Howie and Harlan revisit their conversation with trauma surgeon Selwyn Rogers, whose book Healing the Gun Violence Epidemic: Ending Violence, Rebuilding Communities, and a Trauma Surgeon's Vision for Restoring Hope was published on July 7. Show notes: Selwyn Rogers: Healing the Gun Violence Epidemic: Ending Violence, Rebuilding Communities, and a Trauma Surgeon's Vision fo...

Howie and Harlan are joined by Jessica Federer, managing director of the Women's Health Fund and a member of the Yale Institutional Review Board, to discuss how investors can help address the dearth of research on medical problems facing women and why she's optimistic about the future of women's health. Harlan explains how caps on indirect costs affect institutional staffing and research agendas;...

Howie and Harlan are joined by Yale School of Public Health biostatistician Bhramar Mukherjee to discuss how statisticians help researchers turn observations into evidence. Harlan examines a new study linking updated COVID vaccination to lower cardiovascular risk and explains why a headline-grabbing result may not settle the question; Howie discusses new Medicaid work requirements and the danger t...

Howie and Harlan are joined by Ingrid Katz, director of the Yale Institute for Global Health, to discuss why HIV continues to spread despite the existence of cheap and effective treatment, what AIDS activism can teach us about tackling chronic diseases like hypertension, and what outbreaks like Ebola reveal about the consequences of fragile health systems. Harlan reports on a breach of UK Biobank...

Howie and Harlan discuss healthcare headlines including proposed changes to federal research funding, an outbreak of New World screwworm in Texas cattle, and the debate over free expression after researchers were removed from the American Diabetes Association meeting for distributing an editorial critical of federal science policies. They also examine the future of generic GLP-1 drugs, a new Medic...

Howie and Harlan are joined by Mark Siegel, director of Yale's internal medicine residency program, to discuss his approach to mentoring young physicians and building a medical community grounded in purpose and compassion. Harlan examines a breakthrough targeted therapy that could reshape the treatment of pancreatic cancer and other hard-to-treat cancers; Howie tracks the Ebola outbreak in the Dem...

Howie is joined by guest host Megan Ranney, dean of the the Yale School of Public Health, for a live episode recorded at the Yale Innovation Summit, featuring conversations with five innovators at the intersection of healthcare, public health, and entrepreneurship. Jaya Dadwal , a recent graduate of the School of Public Health and founder of forEVA Health, focused on raising healthcare standards f...

Howie and Harlan are joined by Nicholas Christakis, director of Yale's Human Nature Lab, to discuss his research on social networks, human connection, and the forces that help societies cooperate and endure. Harlan discusses promising phase 3 results for retatrutide, Eli Lilly's experimental "triple G" obesity drug; Howie provides an update on the fast-growing Ebola outbreak in the Democratic Repu...

Howie and Harlan discuss how AI is transforming medical research and publishing, the growing role of consumer health platforms and wearables, new advances in stroke treatment, and the debate over rising hospital costs. They also examine the FDA's approval of flavored vaping products and the nomination of a new surgeon general. Watch a video version of this episode on YouTube. Show notes: Social Me...

Howie and Harlan are joined by Josh Geballe, head of Yale Ventures, to discuss how changes in Yale's mindset, policies, and support systems have helped turn university research into impactful companies. Harlan examines the growing problem of AI-hallucinated citations in published research; Howie provides an update on the deadly Andes hantavirus outbreak aboard a cruise ship. Show notes: Fake Citat...

Howie and Harlan are joined by Lee Schwamm, the Yale School of Medicine's associate dean for digital strategy & transformation and chief digital health officer of the Yale New Haven Health System, to discuss how the system is working to rapidly evaluate and deploy AI tools without compromising patient safety and oversight. Harlan highlights vaccine studies reportedly held back from publication and...

Howie and Harlan are joined by Yale School of Medicine liver specialist Wolfram Goessling, who reflects on his experience surviving a rare cancer and how it reshaped his approach to patient care, communication, and leadership. Harlan discusses a Utah pilot program that is letting AI authorize prescription renewals, prompting alarm from physicians; Howie reports on a study challenging the effective...

Howie and Harlan take on tough questions at the intersection of medicine and society. They trace the deadly history of anti-vaccine activism, unpack Yale's report on trust in higher education, and explore the peptide craze. They also confront the rising moral distress among clinicians working in systems that too often prevent them from caring for patients the way they were trained to. Plus, studen...

Howie and Harlan are joined by Stephen Latham, a Yale School of Medicine senior research scholar and the director of the Yale Interdisciplinary Center for Bioethics. Stephen reflects on his journey to a career at the intersection of law and medicine, and explains why the legal definition of death is becoming less useful in an era of rapidly advancing medical technologies. Harlan unpacks recent ana...

Howie and Harlan are joined by Yale School of Medicine gastroenterologist Deborah Proctor, who reflects on her decades of work in Honduras and how her approach to service has shifted from short-term medical missions to sustained, community-driven partnership. Harlan reports on an AI breakthrough with implications for the security of healthcare systems; Howie marks National Public Health Week with...

Howie and Harlan are joined by trauma surgeon Selwyn Rogers, who reflects on caring for victims of gun violence and speaking with families in their darkest moments—and explains why the problem must be understood as a shared societal responsibility. Harlan examines new evidence suggesting U.S. healthcare spending has grown more slowly than expected; Howie discusses a retracted Lancet article that h...

Howie and Harlan are joined by Yale College and Yale School of Public Health graduate Arya Singh, who reflects on growing up with spinal muscular atrophy, what it takes to build a full life with a disability, and how family support and institutional culture shape what inclusion looks like in practice. Harlan reports on the rapid rise of AI as a front door to health information; Howie responds to t...

Howie and Harlan discuss the end of flu season, vaccine effectiveness, and the challenge of rebuilding public confidence in immunization. Also: new cholesterol guidelines that push earlier treatment, measles outbreaks and the erosion of herd immunity, a court ruling pausing changes to vaccine guidelines, signs of stabilization at the NIH, new evidence on football and brain injury, and a MedPAC rep...

Howie and Harlan are joined by Yale School of Medicine surgical oncologist Kevin Billingsley, who discusses how robotics and advanced imaging are reshaping what it means to be a surgeon and offers guidance for those facing a cancer diagnosis. Harlan reports on a company testing AI-based prescription renewals and raises concerns about safety and oversight; Howie reflects on new survey data showing...

Howie and Harlan are joined by Yale School of Medicine neurologist Kevin Sheth to discuss how collaboration helps drive breakthroughs in brain health, including advances in detecting stroke and other neurological diseases earlier and more precisely. Harlan reflects on lessons from his family's recent experience navigating the healthcare system; Howie examines the expanding marketplace for GLP-1 we...

Howie and Harlan are joined by Yale economist Janet Currie to discuss how early-life investments in health, education, and environmental protection shape children's lifelong well-being and economic opportunity. Harlan highlights a new Medicare payment model that would reward measurable improvements in chronic disease outcomes; Howie reflects on the spread of medical misinformation and a new effort...

Howie and Harlan are joined by Evangelos Oikonomou, a cardiologist and data scientist at the Yale School of Medicine, to discuss how AI can extract overlooked signs of heart disease from routine ECGs, imaging studies, and electronic health records—and how to deploy these AI tools responsibly at scale. Harlan explains whether a widely covered study suggesting that coffee may lower the risk of demen...

Howie and Harlan are joined by geneticist and endocrinologist Joel Hirschhorn to discuss how thousands of genetic variants collectively shape disease and traits like height and obesity. Harlan reviews new research on diet soda and dementia; Howie surveys recent market swings, including the rise of Solace Health and the decline of Hims & Hers. Show notes: Diet Soda and Dementia "Soda consumption an...

Howie and Harlan discuss an escalating measles outbreak in the U.S. and a project piloted by Yale School of Medicine professor Erica Spatz to deliver preventative care in barbershops and beauty salons. Also examined: flu season, nipah virus, and the perils of focusing on healthcare business models. Show notes:  Measles CDC: Measles Outbreak Associated with an Infectious Traveler—Colorado, May–June...